Amphastar Pharmaceuticals AMPH Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's other operating expenses?
- Amphastar Pharmaceuticals (AMPH) reported other operating expenses of $56.69M in Q1 2026.
- How has Amphastar Pharmaceuticals's other operating expenses changed year-over-year?
- Amphastar Pharmaceuticals's other operating expenses increased by 18.2% year-over-year, from $47.96M to $56.69M.
- What is the long-term trend for Amphastar Pharmaceuticals's other operating expenses?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's other operating expenses has grown at a 13.5% compound annual growth rate (CAGR), from $129.85M to $215.65M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.